SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-166711
Filing Date
2022-06-03
Accepted
2022-06-03 07:41:04
Documents
16
Period of Report
2022-06-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d308549d8k.htm   iXBRL 8-K 33551
2 EX-1.1 d308549dex11.htm EX-1.1 209248
3 EX-4.1 d308549dex41.htm EX-4.1 11563
4 EX-5.1 d308549dex51.htm EX-5.1 6232
5 EX-99.1 d308549dex991.htm EX-99.1 8865
  Complete submission text file 0001193125-22-166711.txt   461577

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cnce-20220601.xsd EX-101.SCH 2875
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnce-20220601_lab.xml EX-101.LAB 17995
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnce-20220601_pre.xml EX-101.PRE 11274
10 EXTRACTED XBRL INSTANCE DOCUMENT d308549d8k_htm.xml XML 3358
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 22992905
SIC: 2834 Pharmaceutical Preparations